These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35923065)

  • 21. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK; McCartney CR; Marshall JC
    Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B; Tworowska U; Demissie M; Milewicz A
    Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
    Hoyos LR; Visser JA; McLuskey A; Chazenbalk GD; Grogan TR; Dumesic DA
    Hum Reprod; 2020 Oct; 35(10):2294-2302. PubMed ID: 32918081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic Ovary Syndrome among Obese Adolescents.
    Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
    Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovary syndrome in the pediatric population.
    Bremer AA
    Metab Syndr Relat Disord; 2010 Oct; 8(5):375-94. PubMed ID: 20939704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of markers of endotoxemia in women with polycystic ovary syndrome.
    Banaszewska B; Siakowska M; Chudzicka-Strugala I; Chang RJ; Pawelczyk L; Zwozdziak B; Spaczynski R; Duleba AJ
    Hum Reprod; 2020 Oct; 35(10):2303-2311. PubMed ID: 32869098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.
    Ibáñez L; Oberfield SE; Witchel S; Auchus RJ; Chang RJ; Codner E; Dabadghao P; Darendeliler F; Elbarbary NS; Gambineri A; Garcia Rudaz C; Hoeger KM; López-Bermejo A; Ong K; Peña AS; Reinehr T; Santoro N; Tena-Sempere M; Tao R; Yildiz BO; Alkhayyat H; Deeb A; Joel D; Horikawa R; de Zegher F; Lee PA
    Horm Res Paediatr; 2017; 88(6):371-395. PubMed ID: 29156452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism.
    Rosenfield RL; Ehrmann DA; Barnes RB; Sheikh Z
    Ann N Y Acad Sci; 1993 May; 687():162-81. PubMed ID: 8323171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence.
    Merino PM; Codner E; Cassorla F
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):590-8. PubMed ID: 22218441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.